Rs1128503

From SNPedia
Jump to: navigation, search

is asnp
is mentioned by
dbSNPrs1128503
nextbiors1128503
hapmaprs1128503
1000 genomesrs1128503
hgdprs1128503
ensemblrs1128503
gopubmedrs1128503
scholarrs1128503
googlers1128503
pharmgkbrs1128503
gwascentralrs1128503
openSNPrs1128503
23andMers1128503
23andMe allrs1128503
SNP Nexus

SNPshotrs1128503
SNPdbers1128503
MSV3drs1128503
GeneABCB1
Chromosome7
Orientationminus
Position87179601
ReferenceGRCh37 37.1/131
Max Magnitude0
Geno Mag Summary
(C;C) 0 normal
(C;T) may require more methadone during heroin withdrawal
(T;T) likely to require more methadone during heroin withdrawal
? (C;C) (C;T) (T;T) 28
rs1128503 is a SNP in the transporter P-glycoprotein (P-gp) 170, encoded by the ABCB1 (also known as MDR1) gene. Methadone is a substrate of this protein, so variants may affect the efficacy and optimal dosage of this drug as used for treating opiate dependence.

A study of 98 methadone-maintaining patients concluded that the higher (>150 mg/day) and lower (< or =150 mg/day) methadone dose groups differed significantly in their rs1128503 status (experiment-wise p = 0.0325). Furthermore, individuals with the 3-locus genotype pattern (T;T)-(T;T)-(T;T) for SNPs rs1045642, rs2032582 and rs1128503, respectively, had an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose (point-wise p-value = 0.026).[PMID 18424454]

Neighborrs2235035
Distance515


[PMID 19107781] Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population

PharmGKBPA165110747
NameABCB1:2677G>T/A, mRNA 3095G>T/A, Ala893Ser/Thr
AnnotationRisk or phenotype-associated allele: None. Phenotype: Efflux of P-glycoprotein substrates (verapamil; digoxin; vinblastine; cyclosporin A) in vitro were not significantly affected by combined mutations for rs1128503 (2677G>T/A) and rs1045642 (3435C>T) in LLC-PK1 cell lines. Study size: Triplicate cell assays. Study population/ethnicity: N/A. Significance metric(s): Not significant, p > 0.05. Type of association: FA
GeneABCB1
FeatueExon/Syn
EvidencePubMed ID:12781336
Drugscyclosporine, digoxin, verapamil, vinblastine
Diseases
Curation LevelCurated


[PMID 19437139] ABCB1 single nucleotide polymorphisms in the Brazilian population

PharmGKBPA161145209
NameABCB1:1236C>T
AnnotationThis SNP is well known, but there is no clear consensus on its significance for drug disposition, response or toxicity.
GeneABCB1
FeatueExon/Syn
EvidenceWeb Resource:http://www.pharmgkb.org/search/annotatedGene/abcb1/variant.jsp#ImportantVariantInformationforABCB1-1236
Drugs
Diseases
Curation LevelIn-Depth
PharmGKBPA164944056
NameABCB1:1236T>C, mRNA 1654T>C, Gly412Gly
Annotationpeak blood concentration of cyclosporin A (CsA) was significantly lower in myasthenia gravis patients harboring the 1236 T allele; and trough CsA levels were significantly greater in 1236 TT homozygotes versus CC homozygotes
GeneABCB1
FeatueExon/Syn
EvidencePubMed ID:18717915
Drugscyclosporine
DiseasesMyasthenia Gravis
Curation LevelCurated
PharmGKBPA165291809
NameABCB1:1236C>T
AnnotationRisk or phenotype-associated allele: T. Phenotype: A haplotype of ABCB1 c.1236C>T, c.2677G>A/T, and c.3435C>T (rs1128503, rs2032582 and rs1045642) was associated with increased drug exposure and reduced clearance. Study size: . Study population/ethnicity: Asian patients with Breast Neoplasms treated with doxorubicin. Significance metric(s): p = 0.03 (exposure); p= 0.01 (clearance). Type of association: PK.
GeneABCB1
FeatueExon/Syn
EvidencePubMed ID:18377430
Drugsdoxorubicin
DiseasesBreast Neoplasms
Curation LevelCurated
PharmGKBPA165111372
NameABCB1 1236C>T, ABCB1:1236C>T
AnnotationRisk or phenotype-associated allele: T Phenotype: Carriers of the T variant of ABCB1:1236C>T had lower Autism Treatment Evaluation Checklist (ATEC) scores, indicating improved symptoms and response to risperidone, than CC homozygotes. Study size: 45 Study population/ethnicity: Children with Autism receiving risperidone Significance metric(s): p = 0.002 Type of association: PD
GeneABCB1
FeatueExon/Syn
EvidencePubMed ID:19997080
Drugsrisperidone
DiseasesAutistic Disorder
Curation LevelCurated
PharmGKBPA165111310
NameABCB1: c.1236T>C, mRNA 1654T>C, p.Gly412Gly, ABCB1*8
AnnotationRisk or phenotype-associated allele: rs1128503 TT genotype. Phenotype: Systemic exposure of tipifarnib, based on plasma AUC levels, were 46.5% higher for patients homozygous for ABCB1*8 (3435TT) compared to the CT and CC genotypes. Study size: 28 (16 male). Study population/ethnicity: Caucasian cancer patients, aged 34-75. Significance metric(s): p = 0.047. Type of association: GN; PK
GeneABCB1
FeatueExon/Syn
EvidencePubMed ID:15122075
DrugsTipifarnib
Diseases
Curation LevelCurated
OMIM610064
Desc
Variant
Relatedalso


[PMID 21790905] CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction


[PMID 22015057] Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study


[PMID 22110582] Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients


[PMID 21705081] Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma


[PMID 21806386] Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients


[PMID 22358301] ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients


[PMID 22416375] [Genetic performance criteria valproate in patients with epilepsy]

Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox